3rd Annual Pharmaceutical Tax and Transfer Pricing Congress: Strategies for Tax Optimization, IRS Compliance and Transfer Pricing Planning
November 17-18, 2008
Radisson Plaza - Warwick Hotel - Philadelphia, PA
This conference will provide in-depth information on critical components of deals from a tax perspective, including the following session presented by Mayer Brown partners, Daniel L. Ring and Russell R. Young:
Global Product Liability Management from the Legal and Tax Perspectives
This session presents a dialogue on the tax and legal perspectives with respect to the management of one of the company's greatest potential liabilities. Global product liability exposures in the pharmaceutical industry, of course, are formidable, and have profound impacts on the company's tax and transfer pricing planning. In order to properly understand and plan for the tax issues surrounding product liability exposures, however, it is important to consider the non-tax legal considerations relevant to the company. Hear from a product liability litigator and a tax attorney as they discuss product liability exposures and transfer pricing.
CBI Research, Inc.
For more information or to register, please visit http://www.cbinet.com/or call (339)-298-2142.